Chan, A. (2017). Trastuzumab biosimilar in early breast cancer setting: Will there be direct patient benefits?
Chicago Style (17th ed.) CitationChan, Arlene. Trastuzumab Biosimilar in Early Breast Cancer Setting: Will There Be Direct Patient Benefits? 2017.
MLA (9th ed.) CitationChan, Arlene. Trastuzumab Biosimilar in Early Breast Cancer Setting: Will There Be Direct Patient Benefits? 2017.
Warning: These citations may not always be 100% accurate.